These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1680113)

  • 21. Pharmacological evidence of a role for prejunctional imidazoline (I(1)) receptors in ocular function.
    Ogidigben MJ; Potter DE
    Curr Eye Res; 2002 Nov; 25(5):267-70. PubMed ID: 12658545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of alpha 2-adrenergic receptor agonist and antagonist drugs on cholinergic contraction in bovine tracheal smooth muscle in vitro.
    Manning MM; Broadstone RV
    Am J Vet Res; 1995 Jul; 56(7):930-5. PubMed ID: 7574163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits.
    Potter DE; Burke JA; Ogidigben MJ
    J Auton Pharmacol; 1990 Jun; 10(3):153-61. PubMed ID: 1974256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular hypotensive effects of medetomidine and its analogs.
    Jin Y; Wilson S; Elko EE; Yorio T
    J Ocul Pharmacol; 1991; 7(4):285-96. PubMed ID: 1687323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.
    Weinger MB; Segal IS; Maze M
    Anesthesiology; 1989 Aug; 71(2):242-9. PubMed ID: 2569282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
    Doze V; Chen BX; Li Z; Maze M
    Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors.
    Chu TC; Wong W; Gluchowski C; Hughes BW; Potter DE
    Curr Eye Res; 1996 Sep; 15(9):943-50. PubMed ID: 8921215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference.
    Burke J; Kharlamb A; Shan T; Runde E; Padillo E; Manlapaz C; Wheeler L
    Ann N Y Acad Sci; 1995 Jul; 763():78-95. PubMed ID: 7677389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors.
    Crosson CE; Heath AR; DeVries GW; Potter DE
    Curr Eye Res; 1992 Oct; 11(10):963-70. PubMed ID: 1360396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventilatory, hemodynamic and sedative effects of the alpha 2 adrenergic agonist, dexmedetomidine.
    Zornow MH
    Neuropharmacology; 1991 Oct; 30(10):1065-71. PubMed ID: 1684646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of alpha 2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test.
    Durcan MJ; Lister RG; Linnoila M
    Neuropharmacology; 1989 Mar; 28(3):275-81. PubMed ID: 2566945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antinociceptive properties of intrathecal dexmedetomidine in rats.
    Fisher B; Zornow MH; Yaksh TL; Peterson BM
    Eur J Pharmacol; 1991 Jan; 192(2):221-5. PubMed ID: 1674472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs.
    Kamibayashi T; Mammoto T; Hayashi Y; Yamatodani A; Takada K; Sasaki S; Yoshiya I
    Anesthesiology; 1995 Nov; 83(5):1082-9. PubMed ID: 7486159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics.
    Ogidigben MJ; Potter DE
    Curr Eye Res; 2001 May; 22(5):358-66. PubMed ID: 11600937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog.
    Zornow MH; Fleischer JE; Scheller MS; Nakakimura K; Drummond JC
    Anesth Analg; 1990 Jun; 70(6):624-30. PubMed ID: 1971500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ocular hypotensive effect of alpha-adrenoceptor agonist and antagonist in the conscious pigmented rabbit].
    Moriwaki Y; Iizuka T; Nakamura A; Nakata K; Masaoka Y; Ueda T; Koide R; Inatomi M; Fukado Y; Uchida E
    Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):152-60. PubMed ID: 1348394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intraocular pressure response of conscious rabbits to clonidine.
    Allen RC; Langham ME
    Invest Ophthalmol; 1976 Oct; 15(10):815-23. PubMed ID: 10261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of the ocular hypotensive action of ketanserin.
    Chang FW; Burke JA; Potter DE
    J Ocul Pharmacol; 1985; 1(2):137-47. PubMed ID: 3880071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat.
    Furst SR; Weinger MB
    Anesthesiology; 1990 May; 72(5):882-8. PubMed ID: 1971163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.